The first augmented-reality-assisted total knee replacement with Medacta's NextAR system was performed in December, and now the medtech company aims to expand the technology to spine, hip and shoulder surgery.

Surgalign Spine Technologies has purchased a medical device manufacturing facility to compliment its Spine Innovation Center operations in San Diego.

Spine device company Alphatec reported $44.1 million in first-quarter revenue, an increase of 50 percent compared to the first quarter of 2020.

Steven Goldberg, MD, an orthopedic surgeon at Physicians Regional Medical Center in Naples, Fla., and Zachary Leitze, MD, an orthopedic surgeon with Intermountain Medical Group in St. George, Utah, were among the first surgeons to use Catalyst OrthoScience's Archer R1 reverse shoulder system, Catalyst said this week.

NuVasive saw an increase in net sales, but a decrease in net income during the first quarter of 2021.

Here are seven updates from spine and orthopedic device companies from the last week:

Zimmer Biomet posted $1.8 billion in net sales and $246 million in spine and dental sales in the first quarter. The company has its eyes on new product launches as part of its growth plan this year.

Genesis Software Innovations received 510(k) clearance from the FDA for its PreView Shoulder software for joint replacements.

Globus Medical reported $227.3 million in first-quarter global spine sales, a year-over-year increase of 19.3 percent, with U.S. spine sales rising 22 percent to $193.3 million.

Smith+Nephew launched Aria, a platform for remote physical therapy.

Zimmer Biomet posted $1.8 billion in net sales in the first quarter of 2021 and expects to see up to 17 percent revenue growth this year.

Devicemaker SeaSpine posted $42 million in first quarter revenue, a 16 percent increase compared to the same period in 2020.

Sacropelvic device company SI-Bone reported May 3 that first-quarter revenue increased 22 percent year over year to $20.4 million.

Although Smith+Nephew's overall first quarter revenue has grown since the same period in 2019, orthopedic revenue is still catching up to pre-pandemic figures.

CMS has proposed extending new technology add-on payments for technologies that would otherwise be discontinued in fiscal year 2022.

Orthofix net sales grew in the first quarter, driven by strong U.S. spinal implant sales.

Medical device company Conventus-Flower Orthopedics partnered with Red One Medical, a private sector scout for the Department of Veterans Affairs and Department of Defense.

Smith+Nephew posted $1.3 billion in first-quarter revenue, an 11.5 percent year over-year-increase, with significant growth in hip sales.

Here are seven updates from spine and orthopedic device companies in the last week:

Despite the COVID-19 pandemic, Stryker continued financial growth and has posted gains in its spine and neurotechnology segment since 2019. While the orthopedic segment has grown overall since 2019, the increase was most apparent in trauma and extremities sales.